logo
New NHS tech promises faster diagnosis for millions of cancer patients

New NHS tech promises faster diagnosis for millions of cancer patients

Independent03-05-2025
The NHS is set to speed up cancer diagnoses with the rollout of new technology, Cancer 360.
The tool centralises patient data, enabling clinicians to prioritise urgent cases and expedite treatment.
The NHS says it could lead to faster diagnoses for millions of patients.
Currently, NHS staff grapple with fragmented information scattered across spreadsheets, emails, and various records.
Cancer 360 digitises this analogue system, streamlining the process and providing clinicians with a comprehensive overview of each patient's journey.
The shift eliminates the need for time-consuming data gathering, allowing medical professionals to focus on delivering timely and effective care, the NHS said.
"Every cancer patient deserves swift, effective care, and our new Cancer 360 solution harnesses data to ensure exactly that,' NHS national clinical transformation director Dr Vin Diwakar said.
'By giving clinicians a comprehensive view of patient pathways, we can identify and address delays immediately.
'The NHS federated data platform (FDP) is already showing its value in transforming cancer care, helping our hard-working staff deliver better outcomes while reducing administrative burden. As Cancer 360 expands to more hospitals nationwide, I'm confident we'll see meaningful improvements in both treatment times and patient experience.'
It is understood that trusts will not have to use the tool, but those not meeting the cancer standard – including that 85 per cent of cancer patients should have started their treatment within 62 days of being referred – may be asked to consider how Cancer 360 could help them meet targets.
As well as helping patients get a faster diagnosis, the DHSC said Cancer 360 will also help cut treatment delays and thus boost survival rates.
The technology has been piloted at Royal United Hospitals Bath, and Chelsea and Westminster Hospital.
It helped Chelsea and Westminster Hospital meet the faster diagnosis standard, whereby 75 per cent of patients should receive a diagnosis or ruling out of cancer within 28 days of referral.
Suraiya Abdi, consultant obstetrician and gynaecologist at Chelsea and Westminster Foundation Trust, said: 'The implementation of Cancer 360 has enabled my team to monitor and safely carry our patients through their cancer pathway.
'The tool enables us to have in depth conversations at our weekly meetings regarding a patient's next step as well as allowing us to escalate queries directly to other teams for faster turnaround.
'The tool has reduced the amount of admin time spent by our cancer team therefore enabling them to focus on the patient journey. I have witnessed an improvement in performance, team spirit and most importantly patient experience.'
Technology Secretary Peter Kyle said: 'I've seen first-hand the stress and heartbreak that cancer causes in my own family.
'Dependent on archaic pen-and-paper systems, life-saving diagnostics appointments hung on whether a post-it note lost its stick, or a piece of paper went missing. That put lives at risk, and with the technology we have today, there's no reason for any part of our healthcare service to run in such a way.
'Simply by keeping accurate records, the technology we are putting to work today will cut waiting times and save lives, delivering on our plan for change. That way, people can once again trust that their local hospital has the tools it needs to focus on what matters – treating their loved ones and keeping families together for longer.'
The DHSC said Cancer 360, to be rolled out soon, will benefit millions of patients in the next five to 10 years.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Risk of cancer death drops by 11.1 per cent to record low
Risk of cancer death drops by 11.1 per cent to record low

The National

timean hour ago

  • The National

Risk of cancer death drops by 11.1 per cent to record low

Statistics published by Public Health Scotland (PHS) have shown an 11.1% reduction in mortality rates since 2013, from 333.7 per 100,000 diagnoses to 296.8 per 100,000 in 2022. The data, published on Tuesday, showed the death rates from the illness are the lowest on record since 1998. READ MORE: Chemical company fined £100k after worker suffers 'serious burns' Health Secretary Neil Gray said: 'It is encouraging to see the risk of dying from cancer in Scotland is at a record low. This is down to the hard work of NHS staff, improved treatment options, and people reporting their symptoms at an earlier stage. 'We are determined to further improve cancer survival, reduce waiting times and provide excellent, equitably accessible care right across Scotland.' Due to Scotland's ageing population, 69% of all cancer-related deaths recorded in 2022 were individuals aged 70 or older. 'We are taking action to improve the awareness and earlier diagnosis of cancers, including expanding our Rapid Cancer Diagnostic Services and our investment of more than £14 million towards cancer waiting times this year', Gray continued. 'Reducing health inequalities is a clear ambition for this government. Cutting smoking rates is key to tackling lung cancer incidence in areas of deprivation – our world-leading tobacco control measures are helping us in our goal of a Tobacco-Free Scotland by 2034.' MSP for Rutherglen Clare Haughey welcomed the figures, praising the work of NHS staff and action taken by the Scottish Government to improve both treatment options and early detection initiatives. 'One death from cancer is one too many but these figures are welcome and show the real progress we are making to improve cancer survival under the SNP Government', Haughey said. READ MORE: Ayrshire trust in race to raise £200k for community ownership of B-listed church 'The fact that the likelihood of dying from cancer is at its lowest level on record is testament to the incredible work that staff in our NHS do throughout Scotland every day. 'The SNP is determined to go even further to improve cancer survival across Scotland by taking action to improve awareness and earlier diagnosis of cancers. This includes expanding our Rapid Cancer Diagnostic Services and investing more than £14 million to reduce cancer waiting times this year. 'Whilst other parties continually talk down our NHS, the SNP is getting on with the job of improving and extending lives by investing to tackle health inequalities and improve health outcomes for people right across Scotland.'

People with heart problems to get treatment online as NHS given green light
People with heart problems to get treatment online as NHS given green light

Daily Mirror

time2 hours ago

  • Daily Mirror

People with heart problems to get treatment online as NHS given green light

Seven million people in the UK could be affected by the new draft guidance People suffering from cardiac conditions could soon access rehabilitation programmes from the comfort of their own homes following new draft guidance unveiled on August 19. Six digital platforms have received conditional recommendations from the National Institute for Health and Care Excellence for deployment across the NHS, though the approach won't suit every patient. ‌ Activate Your Heart, D REACH-HF, Digital Heart Manual, Gro Health HeartBuddy, KiActiv and myHeart, are the approved platforms set to be used over a three-year period. They will be used while authorities compile data regarding their long-term effectiveness to tackle certain doubts surrounding the schemes. ‌ These digital rehabilitation services provide fitness regimens, nutritional guidance, learning resources, medicine oversight and mental health assistance. ‌ Certain platforms additionally feature wearable technology to track physical activity levels. Specialists claimed the schemes "offer real potential to transform" the delivery of this care category to individual patients. Approximately seven million Britons are thought to be impacted by cardiovascular illness covered by this fresh guidance, yet conventional rehabilitation schemes suffer from poor participation rates. During 2023, merely 41% of people with acute coronary syndrome, encompassing ailments such as heart attack and angina, took part in cardiac rehabilitation schemes across England. Just 13% of heart failure patients enrolled in the programmes during their recuperation. Rehabilitation for these conditions can slash the risk of additional heart troubles and hospital stays. Currently, these services are typically provided on the NHS through in-person consultations. Participation rates are notably poor amongst women, younger people, ethnic minorities, those in disadvantaged communities and others who find it difficult to attend face-to-face sessions. ‌ It's hoped that shifting this treatment online could boost the number of people getting involved. Dr Anastasia Chalkidou, healthtech programme director at Nice, said: "These digital platforms offer real potential to transform how cardiac rehabilitation is offered to people to meet their individual circumstances. "We know that traditional programmes aren't reaching everyone who could benefit - particularly women, younger patients and people from ethnic minority backgrounds. "The early data is promising and suggests, with safeguards in place, more people should now be given the opportunity to use these new technologies. ‌ "This three-year evidence collection period will give us the additional robust data we need to determine whether these innovations should be recommended as a permanent part of cardiac care." Nevertheless, NICE has acknowledged that the digital rehabilitation won't be appropriate for all patients. A qualified NHS healthcare professional will still be required to carry out a comprehensive clinical evaluation before recommending these platforms to individual patients. Following a three-year period of evidence collection, NICE will assess the data and make a decision on whether the technology can be regularly integrated into the NHS. A consultation on the conditional recommendation is currently in progress and will conclude on 3 September. NICE stated that seven other platforms – Beat Better, Datos Health, Get Ready, Luscii vitals, Pumping Marvellous Cardiac Rehab Platform, R Plus Health and Sword Move – require further research before they can receive NHS funding.

I shed 4st on ‘King Kong' jabs – eggy burps were vile but there's a dangerous potential side effect no one talks about
I shed 4st on ‘King Kong' jabs – eggy burps were vile but there's a dangerous potential side effect no one talks about

Scottish Sun

time2 hours ago

  • Scottish Sun

I shed 4st on ‘King Kong' jabs – eggy burps were vile but there's a dangerous potential side effect no one talks about

Victoria warns that Mounjaro 'isn't an easy fix or magic wand' as she shares key lifestyle changes she's made to combat the horror side effects FAT JAB FEAR I shed 4st on 'King Kong' jabs – eggy burps were vile but there's a dangerous potential side effect no one talks about Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) AFTER dropping four dress sizes and losing 4st 8lbs with the help of Mounjaro, Victoria Turkington thought all of her body woes were over. But the 40-year-old mum-of-three was unprepared for the shock side effects she went on to experience - including a potentially dangerous one that she says nobody talks about. 9 Pictured here at 19 stone, Victoria Turkington is now on a mission to raise awareness on the much darker side of the popular fat jabs Credit: Supplied 9 With her new trimmer figure, Victoria has candidly revealed all on the side effects she experienced whilst using Mounjaro Credit: Supplied 9 Victoria, pictured before her weight loss, dealt with eggy burps and headaches Credit: Supplied 9 But despite slimming down to a size 14, Victoria's real struggle was just beginning Credit: Supplied She told The Sun: 'Mounjaro isn't an easy fix or a magic wand; it still requires hard work and consistency. And users need to be aware of the side effects.' Victoria, from Northumberland, piled on 6 stone after suffering an unexpected and sudden serious spinal injury in 2020. After years spent unsuccessfully trying different weight loss methods, in November 2024, weighing 19 stone, she turned to Mounjaro - nicknamed the 'King Kong' of fat jabs. Since then, Victoria has dropped from a size 22 to a size 14 - but has been confronted by a host of horrendous side effects. Victoria, who works in Forensic Services for the NHS, told Fabulous: 'I get sulphur burps when I eat foods that my tummy doesn't like, such as heavy, dense carbs or greasy foods.' She has also experienced a 'gassy bloated stomach', 'feelings of nausea' and has been woken up on numerous occasions in the night with 'a headache and dry mouth'. But Victoria says she has also experienced a much darker side effect of the jabs. She says: 'I have suffered with my mood and mental health. I found that when on the 7.5mg dose of Mounjaro, I felt no joy in anything. 'My food addiction had disappeared, but so had my joy in shopping, drinking, socialising and my hobbies I once loved like cooking and decorating. 'I felt disinterested, demotivated and fatigued. I stayed on 7.5mg for eight weeks and decided I needed to change the dose, and this, in turn, improved my mood and mental health." Sun Health Explainer: Fat jabs Victoria adds: '10mg has been a great dose, and I'm happy I moved up.' While depression isn't a common side effect of Mounjaro, it's important to note that, like any medication, it can have effects on mood. Dr Tom Curtis, Clinical Head of Obesity at Voy, commented: "The relationship between these medications and mental health is complex, with ongoing research exploring both potential risks and benefits. "On one hand, reports of worsening mood and suicidal behaviour have led regulatory bodies, including the UK's MHRA and the European Medicines Agency, to review safety data. This level of scrutiny shows that a potential link, while not affecting the majority of users, is a serious consideration. "However, some research also suggests these medications could have a beneficial impact on mood for certain individuals. "Several studies have pointed towards potential antidepressant and anti-anxiety effects. "It's thought that the anti-inflammatory properties of GLP-1s may be helpful for the subset of depressive disorders linked to inflammation. "This means the effect on mental health isn't the same for everyone, and scientists are still studying it." For me, the potential side effects outweigh the risk of being obese. There are pros and cons to every medication, but it's changed my life in just 40 weeks so far. Victoria Turkington Dr Curtis, who helped shape NHS services for GLP-1 prescribing, working closely with regulators added: "GLP-1 receptor agonists work on pathways in the brain that regulate not just appetite but also reward, impulse control, and decision-making, primarily through the dopamine system. "It is conceivable that different doses of the medication could affect these complex neural circuits in different ways. "So while there is supporting evidence for the overall safety of these medications from a psychiatric perspective, individual responses can vary significantly. Patients should report any changes in mood or behaviour to their healthcare provider." 'It's changed my life' In current clinical studies, depression has not been strongly linked to Mounjaro as a direct side effect. However, as reported by WebMD, a small number of people taking Mounjaro had reported mood changes, including depression, anxiety, and suicidal thoughts. It's also been revealed that safety warnings about the drug do indicate that it can cause agitation, crankiness, and other abnormal behaviours. While there have been some reports of suicidal thoughts from people taking this medication, Victoria confirmed that she did not experience such thoughts while on the jabs. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. To combat the side effects of Mounjaro, which works by suppressing your appetite and making you feel fuller for longer, Victoria shares: 'I navigated my side effects by using a good multi-vitamin, a probiotic for my gut and a ginger shot every single morning on an empty stomach.' As well as this, Victoria also takes peppermint capsules and collagen to help prevent hair thinning. Victoria had a BMI of 49 prior to starting her Mounjaro journey, which put her in the severely obese category. She says: 'I think it's important that people are aware that, like any medication, Mounjaro comes with side effects. 9 Victoria, pictured here before using fat jabs, "felt no joy in anything" when on the 7.5mg dose of Mounjaro Credit: Supplied 9 Her food addiction disappeared but so had her joy in shopping, drinking, socialising and her hobbies she once loved Credit: Supplied 'People who haven't suffered from obesity will never understand and think that Mounjaro is cheating. 'For me, the potential side effects outweigh the risk of being obese. There are pros and cons to every medication, but it's changed my life in just 40 weeks so far.' Victoria admits she 'tried every diet' before turning to weight loss jabs. She says: 'Slimming World, WeightWatchers, Orlistat slimming pills from the GP… I successfully lost 4st on Slimming World in 2019, but subsequently had to have my gallbladder removed because of rapid weight loss. 'Then in 2020, I was airlifted to hospital due to Cauda Equina - a serious spinal injury. 'I had a nine-hour operation, had to learn to walk again, and was placed on medication from my doctors that is renowned to cause rapid weight gain and makes it difficult to lose weight. 'With my reduced mobility and a further two spinal surgeries in the space of 33 months, I gained a massive six stone. "I tipped the scales at 19st and decided that it was either bariatric surgery abroad or Mounjaro. Different types of weight loss surgery For many people who are overweight or obese, they may feel they have exhausted options for weight loss and want to try something more drastic. Weight loss surgery may be available to them on the NHS if they have a BMI over 40 and have a condition that may be improved with weight loss, such as diabetes. But the availability of these procedures largely depends on where you live in the UK. People can also pay privately. Weight loss surgery is a common and safe procedure. However, as with any operation, there are risks, such as a blood clot, a band slipping out of place, a stomach infection, gallstones and excessive skin from weight loss that in most cases, won't be removed on the NHS. In all of the following options, the space in the stomach is reduced, therefore a person feels fuller after eating less food. They lose weight as a result. However, it is necessary for them to also learn good eating habits and have a healthy balanced diet, too. Gastric bypass The stomach is divided into two using a staple. The smaller part is connected to the intestines, effectively cutting how much space there is in the stomach by half. The operation takes around two hours. Gastric band A band is tied around the top of the stomach and inflated so that it tightens. The operation takes three to four hours. Gastric balloon Patients swallow an empty balloon which is attached to a tube. The balloon is filled with water via the tube, taking around 20 minutes, so that it fills around two-thirds of the stomach space. Sleeve gastrectomy Around 80 per cent of the stomach is removed in surgery to make it much smaller and a sleeve shape. The operation takes between one and three hours. 'I was in communication with a surgeon in Turkey before deciding that Mounjaro was the less invasive and safer option. Mounjaro was my only way.' Victoria says her weight dropped quickly in the first few months, but the loss has since slowed down. She adds: 'I've gone from 19st to 14st 6lb. I was a size 22 and am now a size 14.' Now, at 5ft 2, she finds herself in the obese category with a BMI of 37.8, continues: 'My goal is to be a comfortable size 12 and roughly under 11 stone.' Whilst using the fat jabs, Victoria, who has 'limited mobility' and as a result, finds exercising "difficult,' focused on eating in a calorie deficit, which involves consuming fewer calories than your body needs to maintain its current weight. I give real and raw updates. Mounjaro isn't an easy fix or a magic wand, it still requires hard work and consistency. Although people's opinions differ, it's working for me.' Victoria Turkington As well as cutting her calories, Victoria is also avoiding fried food, red meat, dense carbs and anything spicy whilst on the injections. She shares: 'I have stuck to a calorie deficit since November and try to implement pilates, yoga and resistance band training. 'I drink three to four litres of water per day and focus on my macros, protein, fibre and fat. 'I am enjoying educating myself in diet and nutrition, and I'm now building a much better relationship with food.' As well as this, Victoria is also focusing on 'rewiring' her brain and 'building better habits' that are now part of her lifestyle, which she plans to continue into the future. 'I am coming up to week 40 on my journey now and have another 40lbs to my goal. I would be thrilled if I could get to my goal weight for the new year.' Eager to encourage others to seek medical advice when experiencing side effects, Victoria recognises: 'There is a yellow card scheme with the MHRA [Medicines and Healthcare products Regulatory Agency] and anyone experiencing side effects not listed in the information leaflet included with your medication should be reported and people should always speak to their provider if they're concerned. 9 Prior to losing weight, Victoria was a size 22 Credit: Supplied 9 Now, she's dropped down to the obese category with a BMI of 37.8 Credit: Supplied 9 Mounjaro is typically used to treat type 2 diabetes but is now being used to "save the lives of people with 'life-threatening levels of obesity" Credit: Getty 'I am a Company ambassador for Öushk pharmacy and the support they have provided me with is second to none.' As well as this, she warns fat jab users: 'It's important people get Mounjaro through a registered pharmacy and find a pharmacy that is responsive and supportive.' Eager to be open about her Mounjaro use, Victoria has shared her experience with her social media fans: 'Across my three social media platforms, I have around 45,000 followers and find that it helps me to share my experience and my journey with others. 'I give real and raw updates. Mounjaro isn't an easy fix or a magic wand, it still requires hard work and consistency. Although people's opinions differ, it's working for me.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store